Q32 Bio (QTTB) Return on Capital Employed (2018 - 2025)
Historic Return on Capital Employed for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to 0.86%.
- Q32 Bio's Return on Capital Employed fell 800.0% to 0.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 1.24% for FY2024, which is 8500.0% down from last year.
- According to the latest figures from Q3 2025, Q32 Bio's Return on Capital Employed is 0.86%, which was down 800.0% from 0.9% recorded in Q2 2025.
- In the past 5 years, Q32 Bio's Return on Capital Employed registered a high of 0.39% during Q2 2021, and its lowest value of 0.9% during Q2 2025.
- In the last 5 years, Q32 Bio's Return on Capital Employed had a median value of 0.55% in 2024 and averaged 0.61%.
- As far as peak fluctuations go, Q32 Bio's Return on Capital Employed surged by 1500bps in 2021, and later plummeted by -3500bps in 2025.
- Over the past 5 years, Q32 Bio's Return on Capital Employed (Quarter) stood at 0.47% in 2021, then decreased by -27bps to 0.6% in 2022, then fell by -2bps to 0.61% in 2023, then plummeted by -33bps to 0.81% in 2024, then fell by -6bps to 0.86% in 2025.
- Its last three reported values are 0.86% in Q3 2025, 0.9% for Q2 2025, and 0.89% during Q1 2025.